Stay updated on Nivolumab-Ipilimumab vs Sunitinib in Advanced RCC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab-Ipilimumab vs Sunitinib in Advanced RCC Clinical Trial page.

Latest updates to the Nivolumab-Ipilimumab vs Sunitinib in Advanced RCC Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe Publications section note was revised to indicate that publications are automatically filled from PubMed. The revision tag was updated from v3.2.0 to v3.3.2.SummaryDifference0.0%

- Check26 days agoChange DetectedAn administrative funding banner was removed from the page. The core study details and data remain unchanged.SummaryDifference0.1%

- Check47 days agoChange DetectedAdministrative updates were made to study record dates and the last verified timestamp. The core interventions, outcomes, and eligibility criteria remain unchanged.SummaryDifference0.1%

- Check70 days agoChange DetectedVersion bumped to v3.2.0 with an added government-operating-status notice; the previous v3.1.0 deletion indicates the page now reflects the updated version.SummaryDifference2%

- Check77 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other substantive content changes detected.SummaryDifference0.0%

- Check92 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; a 'Back to Top' element was removed. No core content, pricing, stock, or time slots were altered.SummaryDifference0.1%

Stay in the know with updates to Nivolumab-Ipilimumab vs Sunitinib in Advanced RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab-Ipilimumab vs Sunitinib in Advanced RCC Clinical Trial page.